Mei‐Ren Pan

Kaohsiung Medical University — Taiwan

Biochemistry, Genetics and Molecular Biology · Life Sciences

30h-index2.4kcitations91works1.72yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer-related gene regulation(19), Epigenetics and DNA Methylation(17), Kruppel-like factors research(13), Cancer Cells and Metastasis(12), DNA Repair Mechanisms(11)

Publications91 total

Deglycosylated PD-L1 is a biomarker for immune checkpoint blockade response: a real-world study in breast cancer patients in Taiwan
Cancer Letters·2025· 1 cited
Targeting Bmi1 for Enhancing Anoikis Sensitivity and Inhibiting Metastasis in Colorectal Cancer
Cancer Genomics & Proteomics·2024· 4 citedOpen Access
Targeting the CDK7-MDK axis to suppresses irinotecan resistance in colorectal cancer
Life Sciences·2024· 4 cited
Efficacy of the minimal-invasive vacuum-assisted biopsy under direct visualization with ultrasound for impalpable breast lesions in Taiwanese female: A retrospective case-control study
Formosan Journal of Surgery·2024Open Access
Chromatin Remodeling-Related PRDM1 Increases Stomach Cancer Proliferation and Is Counteracted by Bromodomain Inhibitor
Journal of Personalized Medicine·2024Open Access
Evaluating Recurrence Risk in Patients Undergoing Breast-conserving Surgery Using E-cadherin Staining as a Biomarker
In Vivo·2024· 1 citedOpen Access
The Prognosis Performance of a Neutrophil- and Lymphocyte-Associated Gene Mutation Score in a Head and Neck Cancer Cohort
Biomedicines·2023· 1 citedOpen Access
The role of the genomic mutation signature and tumor mutation burden on relapse risk prediction in head and neck squamous cell carcinoma after concurrent chemoradiotherapy
Experimental & Molecular Medicine·2023· 5 citedOpen Access
Combination of FAK inhibitor and cytokine-induced killer cell therapy: An alternative therapeutic strategy for patients with triple-negative breast cancer
Biomedicine & Pharmacotherapy·2023· 13 citedOpen Access
Supplementary Figure 4 from Prospero Homeobox 1 Promotes Epithelial–Mesenchymal Transition in Colon Cancer Cells by Inhibiting E-cadherin via miR-9
2023Open Access
Supplementary Figure 1 from Prospero Homeobox 1 Promotes Epithelial–Mesenchymal Transition in Colon Cancer Cells by Inhibiting E-cadherin via miR-9
2023Open Access
Data from Prospero Homeobox 1 Promotes Epithelial–Mesenchymal Transition in Colon Cancer Cells by Inhibiting E-cadherin via miR-9
2023Open Access
Supplementary Figure 6 from Prospero Homeobox 1 Promotes Epithelial–Mesenchymal Transition in Colon Cancer Cells by Inhibiting E-cadherin via miR-9
2023Open Access
Supplementary Figure 2 from Prospero Homeobox 1 Promotes Epithelial–Mesenchymal Transition in Colon Cancer Cells by Inhibiting E-cadherin via miR-9
2023Open Access
Supplementary Figure 1 from Prospero Homeobox 1 Promotes Epithelial–Mesenchymal Transition in Colon Cancer Cells by Inhibiting E-cadherin via miR-9
2023Open Access
Data from Prospero Homeobox 1 Promotes Epithelial–Mesenchymal Transition in Colon Cancer Cells by Inhibiting E-cadherin via miR-9
2023Open Access
Supplementary Figure 4 from Prospero Homeobox 1 Promotes Epithelial–Mesenchymal Transition in Colon Cancer Cells by Inhibiting E-cadherin via miR-9
2023Open Access
Supplementary Figure 5 from Prospero Homeobox 1 Promotes Epithelial–Mesenchymal Transition in Colon Cancer Cells by Inhibiting E-cadherin via miR-9
2023Open Access
Supplementary Figure 3 from Prospero Homeobox 1 Promotes Epithelial–Mesenchymal Transition in Colon Cancer Cells by Inhibiting E-cadherin via miR-9
2023Open Access
Supplementary Figure 5 from Prospero Homeobox 1 Promotes Epithelial–Mesenchymal Transition in Colon Cancer Cells by Inhibiting E-cadherin via miR-9
2023Open Access
page 1 of 5Next →

Frequent Co-authors

Chi‐Wen Luo(23), Wen‐Chun Hung(19), Ming‐Feng Hou(15), Wen-Chun Hung(10), Chun‐Chieh Wu(10), Shu‐Jyuan Chang(10), Li‐Tzong Chen(9), Hui‐Ching Wang(9), Ming‐Chuan Hsu(7), Tzu-Yi Chen(7), Chee‐Yin Chai(6), Guang Peng(5), Shiaw‐Yih Lin(5), Hui‐Chiu Chang(4), Cheng-Che Wu(4), Fu Ou‐Yang(4), Yin-Chou Hsu(4), Chien‐Feng Li(4), Chun‐Chieh Wu(4), Shao‐Yu Fang(4)